UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 305

Sortiert nach

Remdesivir for 5 or 10 Days in Patients with Severe Covid-19

The New England journal of medicine, 2020-11, Vol.383 (19), p.1827-1837

2020

Link zum Volltext

Verfügbarkeit prüfen

Accessible Hepatitis C Care for People Who Inject Drugs: A Randomized Clinical Trial

JAMA internal medicine, 2022-05, Vol.182 (5), p.494

2022

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis C Management Simplification From Test to Cure: A Framework for Primary Care Providers

Clinical therapeutics, 2018-08, Vol.40 (8), p.1234-1245

2018

Link zum Volltext

Verfügbarkeit prüfen

Assessing routes of hepatitis C transmission in HIV-infected men who have sex with men using single genome sequencing

PloS one, 2020-07, Vol.15 (7), p.e0235237-e0235237

2020

Link zum Volltext

Verfügbarkeit prüfen

The impact of COVID-19 on people who inject drugs in New York City: increased risk and decreased access to services

Harm reduction journal, 2021-11, Vol.18 (1), p.118-118, Article 118

2021

Link zum Volltext

Verfügbarkeit prüfen

"Treated like a Human Being": perspectives of people who inject drugs attending low-threshold HCV treatment at a syringe service program in New York City

Harm reduction journal, 2023-07, Vol.20 (1), p.95-95

2023

Link zum Volltext

Verfügbarkeit prüfen

Immunogenicity and Safety of Hepatitis B Virus (HBV) Vaccine With a Toll-Like Receptor 9 Agonist Adjuvant in HBV Vaccine-Naïve People With Human Immunodeficiency Virus

Clinical infectious diseases, 2023-08, Vol.77 (3), p.414-418

2023

Link zum Volltext

Verfügbarkeit prüfen

Rapid Progression to Decompensated Cirrhosis, Liver Transplant, and Death in HIV-infected Men After Primary Hepatitis C Virus Infection

Clinical infectious diseases, 2013-04, Vol.56 (7), p.1038-1043

2013

Link zum Volltext

Verfügbarkeit prüfen

Sofosbuvir Plus Ribavirin Without Interferon for Treatment of Acute Hepatitis C Virus Infection in HIV-1–Infected Individuals: SWIFT-C

Clinical infectious diseases, 2017-04, Vol.64 (8), p.1035-1042

2017

Link zum Volltext

Verfügbarkeit prüfen

Remdesivir Treatment for Severe COVID-19 in Third-Trimester Pregnancy: Case Report and Management Discussion

Open forum infectious diseases, 2020-09, Vol.7 (9), p.ofaa345-ofaa345

2020

Link zum Volltext

Verfügbarkeit prüfen

Risk factors for hepatitis C seropositivity among young people who inject drugs in New York City: Implications for prevention

PloS one, 2017-05, Vol.12 (5), p.e0177341-e0177341

2017

Link zum Volltext

Verfügbarkeit prüfen

Rapid Treatment Initiation for Hepatitis C Virus Infection: Potential Benefits, Current Limitations, and Real-World Examples

Gastroenterology & hepatology, 2022-11, Vol.18 (11), p.628-638

2022

Link zum Volltext

Verfügbarkeit prüfen

Rapid Treatment Initiation for Hepatitis C in Young People Who Inject Drugs: The Seek, Test, and Rapid Treatment Randomized Trial

Open forum infectious diseases, 2022-07, Vol.9 (7), p.ofac225-ofac225

2022

Link zum Volltext

Verfügbarkeit prüfen

Ledipasvir/Sofosbuvir for 8 Weeks to Treat Acute Hepatitis C Virus Infections in Men With Human Immunodeficiency Virus Infections: Sofosbuvir-Containing Regimens Without Interferon for Treatment of Acute HCV in HIV-1 Infected Individuals

Clinical infectious diseases, 2019-07, Vol.69 (3), p.514-522

2019

Link zum Volltext

Verfügbarkeit prüfen

Management of hepatitis B and C infections in rheumatologic disease

Best practice & research. Clinical rheumatology, 2018-12, Vol.32 (6), p.848-868

2018

Link zum Volltext

Verfügbarkeit prüfen

Effects of sofosbuvir-based hepatitis C treatment on the pharmacokinetics of tenofovir in HIV/HCV-coinfected individuals receiving tenofovir disoproxil fumarate

Journal of antimicrobial chemotherapy, 2018-08, Vol.73 (8), p.2112-2119

2018

Link zum Volltext

Verfügbarkeit prüfen

Strategies for Improving Hepatitis C Treatment Access in the United States: State Officials Address High Drug Prices, Stigma, and Building Treatment Capacity

Journal of public health management and practice, 2019-05, Vol.25 (3), p.245

2019

Link zum Volltext

Verfügbarkeit prüfen

Cost of providing co-located hepatitis C treatment at a syringe service program exceeds potential reimbursement: Results from a clinical trial

Drug and alcohol dependence reports, 2022-12, Vol.5, p.100109, Article 100109

2022

Link zum Volltext

Verfügbarkeit prüfen

Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: A U.S.–Canadian multicenter study

Journal of hepatology, 2007-10, Vol.47 (4), p.527-537

2007

Link zum Volltext

Verfügbarkeit prüfen

Diagnosis and Genotyping of Coxiella burnetii Endocarditis in a Patient with Prosthetic Pulmonary Valve Replacement Using Next-Generation Sequencing of Plasma Microbial Cell-Free DNA

Open forum infectious diseases, 2019-06, Vol.6 (6), p.ofz242-ofz242

2019

Link zum Volltext

Verfügbarkeit prüfen

The first wave: HCV NS3 protease inhibitors telaprevir and boceprevir

Antiviral therapy, 2012, Vol.17 (6), p.1119-1131

2012

Link zum Volltext

Verfügbarkeit prüfen

Histological Findings and Clinical Characteristics Associated with Hepatic Steatosis in Patients Coinfected with HIV and Hepatitis C Virus

The Journal of infectious diseases, 2005-12, Vol.192 (11), p.1943-1949

2005

Link zum Volltext

Verfügbarkeit prüfen

Risk factors for thrombocytopenia in HIV-infected persons in the era of potent antiretroviral therapy

Journal of acquired immune deficiency syndromes (1999), 2009-12, Vol.52 (5), p.595

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 305

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(272)
Mit Volltextzugriff
(255)

Publikationsform

Sprache

Englisch
(305)
Japanisch
(38)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Remdesivir for 5 or 10 Days in Patients with Severe Covid-19

Accessible Hepatitis C Care for People Who Inject Drugs: A Randomized Clinical Trial

Hepatitis C Management Simplification From Test to Cure: A Framework for Primary Care Providers

Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection

Assessing routes of hepatitis C transmission in HIV-infected men who have sex with men using single genome sequencing

The impact of COVID-19 on people who inject drugs in New York City: increased risk and decreased access to services

Compassionate Use of Remdesivir in Pregnant Women With Severe Coronavirus Disease 2019

"Treated like a Human Being": perspectives of people who inject drugs attending low-threshold HCV treatment at a syringe service program in New York City

Immunogenicity and Safety of Hepatitis B Virus (HBV) Vaccine With a Toll-Like Receptor 9 Agonist Adjuvant in HBV Vaccine-Naïve People With Human Immunodeficiency Virus

Rapid Progression to Decompensated Cirrhosis, Liver Transplant, and Death in HIV-infected Men After Primary Hepatitis C Virus Infection

Sofosbuvir Plus Ribavirin Without Interferon for Treatment of Acute Hepatitis C Virus Infection in HIV-1–Infected Individuals: SWIFT-C

Remdesivir Treatment for Severe COVID-19 in Third-Trimester Pregnancy: Case Report and Management Discussion

Risk factors for hepatitis C seropositivity among young people who inject drugs in New York City: Implications for prevention

Rapid Treatment Initiation for Hepatitis C Virus Infection: Potential Benefits, Current Limitations, and Real-World Examples

Rapid Treatment Initiation for Hepatitis C in Young People Who Inject Drugs: The Seek, Test, and Rapid Treatment Randomized Trial

Ledipasvir/Sofosbuvir for 8 Weeks to Treat Acute Hepatitis C Virus Infections in Men With Human Immunodeficiency Virus Infections: Sofosbuvir-Containing Regimens Without Interferon for Treatment of Acute HCV in HIV-1 Infected Individuals

Management of hepatitis B and C infections in rheumatologic disease

Effects of sofosbuvir-based hepatitis C treatment on the pharmacokinetics of tenofovir in HIV/HCV-coinfected individuals receiving tenofovir disoproxil fumarate

Strategies for Improving Hepatitis C Treatment Access in the United States: State Officials Address High Drug Prices, Stigma, and Building Treatment Capacity

Cost of providing co-located hepatitis C treatment at a syringe service program exceeds potential reimbursement: Results from a clinical trial

Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: A U.S.–Canadian multicenter study

Diagnosis and Genotyping of Coxiella burnetii Endocarditis in a Patient with Prosthetic Pulmonary Valve Replacement Using Next-Generation Sequencing of Plasma Microbial Cell-Free DNA

The first wave: HCV NS3 protease inhibitors telaprevir and boceprevir

Histological Findings and Clinical Characteristics Associated with Hepatic Steatosis in Patients Coinfected with HIV and Hepatitis C Virus

Risk factors for thrombocytopenia in HIV-infected persons in the era of potent antiretroviral therapy

Suchergebnisse filtern